In brief
The Democratic Republic of the Congo’s Ebola outbreak has escalated to more than 5,000 deaths, surpassing 10,000 confirmed cases, with a fatality rate near 50‑52% according to multiple reports. Sources differ slightly on figures, reflecting timing rather than methodology. All note the disease’s severity, but few mention approved treatments or vaccines.
In a late‑October 2026 update, the Ministry of Health of the Democratic Republic of the Congo announced that 5,340 people had died from the Ebola virus out of 10,351 confirmed infections, a case‑fatality rate of 51.6 %. The figure was reported by the Saudi Press Agency (SPA) and underscores the severity of the current outbreak.
The SPA statement, published on the ministry’s website, noted that the data were current as of October 29, 2026. It added that the fatality rate, at 51.6 percent, remained high compared with earlier stages of the epidemic.
Aljazeera’s online report, accessed a day later, observed that the death toll had “passed 5,000” and that authorities were “struggling to find a way to control the outbreak, with no approved treatments or vaccines.” This comment highlights the severe public‑health challenge and the lack of effective medical countermeasures.
CGTN, citing the ministry’s figures, reported that the death toll had “surpassed 5,000,” with “more than 10,000 confirmed infections.” The Chinese broadcaster’s account fits the national health data but does not provide the specific death count or fatality rate.
Fox 40 AP International reported a slightly lower death toll—5,026 deaths out of 10,351 cases—thereby giving a lethality rate “nearly 50 percent.” The outlet also noted that the deaths represented “nearly half” of the confirmed cases, echoing the catastrophic nature of the outbreak.
When the data are compared, the differences in the reported death counts stem mainly from the timing of each source’s reporting. The SPA’s figure (5,340) reflects the national ministry data available on October 29, while the Fox 40 and CGTN figures are published in the 24- to 48‑hour window following the same national update, accounting for a modest increase as further deaths were recorded. The Aljazeera figure of “passed 5,000” is a more general estimate that corroborates the rise without specifying a final count.
All sources agree that the case‑fatality rate remains extremely high—between 50 and 52 percent—and that the outbreak’s persistence points to systemic challenges, including low vaccine coverage, limited treatment availability, and health‑system strain. No outlet reported the appearance of new therapies, and Aljazeera specifically noted the absence of approved treatments or vaccines.
Across reports, the narrative is one of an urgent public‑health crisis: more than 10,000 people infected, a fatality rate that keeps the outbreak among the deadliest in recent memory, and a persistent lack of effective medical interventions. Officials are calling for coordinated international aid, vaccine deployment, and improved surveillance, while international observers caution that the global community must remain alert to the risk of further spread.
